One of the most exciting developments in the field of medicine over the last 20 years has been the introduction of advanced data analytics techniques to allow physicians to make better decisions in the treatment of their patients. One of the areas which this has made the most profound impact has been the field of cancer research and treatment. With the advent of precision medicine, the techniques of big data are creating huge synergies and allowing for cancer to be treated in ways never before imagined.
At the forefront of this movement to marry big data techniques to cancer treatment is a man by the name of Eric Lefkofsky. Many people have heard of Eric Lefkofsky due to his role in the founding of group discount giant Groupon. But thy prolific entrepreneur has now taken on one of the most challenging projects of his career. He has decided to attempt to revolutionize the way in which cancer is treated, eventually hoping it will lead to something like a cure. Through his company, Tempus, Lefkofsky is taking concrete steps towards allowing doctors to have almost unlimited and actionable data at their disposal.
Lefkofsky’s entry into the cancer treatment space was the result of an unfortunate confluence of events. In 2013, Lefkofsky’s wife was diagnosed with late-stage breast cancer. This was a stunning diagnosis to both Lefkofsky and his wife, as she had been feeling more or less perfectly fine. Over the course of the next two years, Lefkofsky accompanied his wife to dozens of oncology appointments. He was struck by the fact that most of the oncologists with whom he interacted had less availability of data than the typical truck driver in the United States today and learn more about Eric Lefkofsky.
Lefkofksy immediately recognized something needed to be done to close this gigantic gap in a very important market. He began a long period of researching ways in which oncological data can be presented intelligibly and in real-time to the treating physicians. This project eventually gave rise to the founding of startup Tempus.
Lefkofky is optimistic that over the next 10 years Tempus will be able to revolutionize the ways in which physicians and oncologists are able to treat their patients through data informed decisions and more information click here.